[BDRX] YoY Annual Result on 31-Dec-2022 [#FY]

Stock
[BDRX] Biodexa Pharmaceuticals Plc
Announcement Date
30-Dec-2022
Financial Year
2022
Quarter
31-Dec-2022 [#FY]
Profit Trend
YoY- -40.22%
Quarter Report
BDRX's Result
BDRX's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 381 699 578 343 674 1,938 989 -14.69%
PBT -7,485 -8,488 -6,106 -23,470 -10,923 -12,400 -12,970 -8.75%
Tax -406 832 646 1,281 1,785 2,032 1,265 -
NP -7,079 -7,656 -5,460 -22,189 -9,138 -10,368 -11,705 -8.03%
Tax Rate - - - - - - - -
Total Cost 7,460 8,355 6,038 22,532 9,812 12,306 12,694 -8.47%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -1,858.01 -1,095.28 -944.64 -6,469.10 -1,355.79 -534.98 -1,183.52 7.80%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -224.13 -619.72 -542.31 -4,143.60 -3,988.65 0.00 0.00 -
EPS Diluted -224.13 -619.72 -542.31 -4,143.60 -3,988.65 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.